Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 352 results for "Zohydro"

More on Zogenix Q2 results

Zogenix ( ZGNX ) Q2 results : Total Revenue: $9.2M (+3.4%), Zohydro Sales: $2.4M; Operating Loss: ($45.8M) (-314.0%); Net Income: $62.9M (+572.9%); EPS: $0.45 (+446.2%); Quick Assets: $81.2M (+12.8%). Zohydro ER prescriptions: 10,299. No specific ... Seeking Alpha, 1 month ago

13 images for Zohydro

WABC New York City, 2 weeks ago
Champlain Channel, 3 weeks ago
Champlain Channel, 3 weeks ago
WABC New York City, 2 weeks ago
SPi World News, 2 weeks ago
WABC New York City, 1 month ago, 2 months ago, 2 months ago, 2 months ago, 2 months ago

Despite The Sell-Off, Zohydro Is A Falling Knife Too Dangerous To Catch

Summary Zohydro will stay on the market after multiple clear signals from the FDA standing by its approval. The real question is if doctors will prescribe the drug given the crowded space with multiple generics options. I spoke with 2 physicians, ...
 Seeking Alpha1 month ago
SPi World News

New Data Shows Zohydro(R) ER Reduced Pain and Improved Function in People With Chronic Pain

PHOENIX, Sept. 18, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. ( Nasdaq:ZGNX ), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, today presented data from a one ...
 CEOWorld Magazine1 day ago New Data Show Zohydro ER Reduced Pain and Improved Function in People With Chronic Pain  FirstWord Pharma1 day ago Zogenix, Inc. Release: New Data Shows Zohydro┬« ER Reduced Pain And Improved Function In People With Chronic Pain  BioSpace1 day ago Zogenix (ZGNX) Gains; New Data Shows Zohydro ER Reduces Pain  Industrial Info Financials1 day ago

New Prescription Opiate Zohydro Has Strong Potential for Abuse Warns Aid in Recovery

, a full service drug and alcohol treatment center, released a statement today regarding the potential for abuse of a dangerous new painkiller, Zohydro, which is marketed to chronic pain sufferers. The drug, an extended-release painkiller that ...
 Digital Journal3 weeks ago

New England Governors Call on Federal Government to Rescind Zohydro Approval

The governors of five New England states have asked the U.S. Department of Health and Human Services (HHS) to rescind approval of Zohydro ER, a pure form of the opioid hydrocodone. The governors of Massachusetts, Vermont, New Hampshire, Rhode ...
 Partnership for Drug-Free Kids1 week ago New England Governors urge HHS to reject Zohydro ER; Support Canadian action  FiercePharma2 weeks ago

Governors to HHS secretary: Nix that FDA nod for controversial painkiller Zohydro

Count 5 U.S. governors among the lobbyists for a turnabout on the powerful painkiller Zohydro. The New England politicians wrote Health and Human Services Secretary Sylvia Burwell last week, urging her to yank the drug's FDA approval. Citing "an ...
 FiercePharma2 weeks ago Governors to HHS secretary Nix that FDA nod for controversial painkiller Zohydro  Big News Network2 weeks ago

Zogenix seeks partner, steers Zohydro marketing away from weak New England

Marketing can be a bit like dating. If you're not getting results with one target, then it's best to focus on someone else. That's exactly what Zogenix ($ZGNX) is doing, by tweaking its Zohydro launch strategy. The controversial new ...
 FiercePharma1 month ago Zogenix seeks partner steers Zohydro marketing away from weak New England  Big News Network1 month ago

Who's Afraid of Zohydro?

Credit Illustration by Jon Han. If a good politician is somebody who, to paraphrase Winston Churchill, never lets a serious crisis go to waste, then Deval Patrick, the governor of Massachusetts, is an excellent politician. In March, responding to ...
 New Yorker1 month ago
Mergers & Acquisitions

Struggling Drug Developer Zogenix Wins Massachusetts Lawsuit

The company won the right to sell painkiller Zohydro in Massachusetts, and plans to develop an abuse-deterrent variation of the drug July 22, 2014 Struggling pharmaceutical company Zogenix Inc. has won the right to sell its Zohydro ER ...
 Mergers & Acquisitions1 month ago

Did the FDA overestimate the need for the synthetic heroin painkiller Zohydro?

that defends the support by the Institute of Medicine (IOM) of the FDA's release of Zohydro, a pure form to synthetic heroin. The statistic used by IOM to defend the release of Zohydro, which is now the most potent pharmaceutical pain killer, is ...
 Examiner.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less